Загрузка...
Novel non-invasive biomarkers that distinguish between benign prostate hyperplasia and prostate cancer
BACKGROUND: The objective of this study was to discover and to validate novel noninvasive biomarkers that distinguish between benign prostate hyperplasia (BPH) and localized prostate cancer (PCa), thereby helping to solve the diagnostic dilemma confronting clinicians who treat these patients. METHOD...
Сохранить в:
Опубликовано в: : | BMC Cancer |
---|---|
Главные авторы: | , , , , , , , , , |
Формат: | Artigo |
Язык: | Inglês |
Опубликовано: |
BioMed Central
2015
|
Предметы: | |
Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4433087/ https://ncbi.nlm.nih.gov/pubmed/25884438 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1284-z |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|